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Abstract  Background: Thrombo-
cytopenia occurring in falciparum 
malaria infection has been docu-
mented worldwide. However, its 
prevalence varies from place to 
place, and among different popu-
lation groups studied. There is 
paucity of data on this in Nigerian 
children.  
Objectives: To determine the 
prevalence of thrombocytopenia 
in children presenting with falci-
parum malaria at the University 
of Uyo Teaching Hospital, Uyo, 
Akwa Ibom State, Nigeria. 
Method: A prospective cross-
sectional study from October 
2010 to March 2011 on one hun-
dred and eighty children with mi-
croscopically confirmed malaria 
aged six months to fifteen years, 
compared with 180 healthy chil-
dren without malaria parasitaemia 
matched for age and gender. Their 
platelet counts were evaluated  
using the auto-analyser Sysmex  
KX-21N.  
Results: The overall prevalence of 
thrombocytopenia was 5.0%, but it 
was higher in children with severe 
malaria. None of the children in 
the control group had thrombocy-
topenia. 
Conclusion: The prevalence of 
thrombocytopenia in falciparum 
malaria is low in our setting, but 
higher in children with severe 
manifestations of malaria. 
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Malaria infection remains a major public health problem 
and cause of morbidity and mortality in all age groups.1,2 
In Nigeria, it accounts for 20 to 30% of infant and child 
mortality, particularly in children who are five years of 
age and younger. 2,3 The lethality of P. falciparum com-
pared with other species of plasmodium probably stems 
from the parasite density it achieves which is typically a 
hundred times higher than that of other species before its 
proliferation is curtailed by host defence mechanisms.2 
As blood parasites for most of their complex life cycle, 
plasmodia, not surprisingly, produce haematological 
abnormalities that include anaemia, thrombocytopenia, 
splenomegaly and rarely disseminated intravascular co-
agulation with a bleeding diathesis.2,3-6 Values of haema-
tological parameters have been shown to be affected by 
factors such as genetics and ethnic differences, sex, age, 
environmental factors like dietary pattern and altitude.3-5 
Since these factors differ depending on the population 
and geographical area studied, it is not surprising that 
differences have been reported in these parameters 
worldwide.3-5  
 
Genetic factors are shown to significantly contribute to 
variance in all blood cell lines. 7-9 Thus within the wide 
“normal reference range”, there are some ethnic differ-
ences, with Caucasian values being higher than those of 
the African and Afro-carribeans.7-10 It has therefore been 
stressed that each population must establish its own
“normal reference values” for use in clinical asses-
ments.7,10 The normal reference range of the platelet 
count in the African population has been established at 
100 – 300 x 109/L.7-9 For the Caucasians, it is 150 – 450 
x 109/L.2,7,9 These differences in normal values need to 
be appreciated to avoid fundamental errors in the ass ss-
ment and management of patients. 
 
Thrombocytopenia, a state of reduced circulating plate-
let count in blood below the normal level can be caused 
by decreased platelet production, increased destruction, 
sequestration or a combination of these.2 A major aeti-
ologic cause for acquired thrombocytopenia of child-
hood is increased platelet destruction associated with
several clinical conditions including protozoal infections 
such as malaria especially in the tropical regions.2,3,6 
This association of thrombocytopenia with malaria in-
fection is well recognized, but prevalence varies with 
levels of malarial endemicity and immunity, age, malar-
ial specie and malarial severity.11-13 Studies from various 
authors in different regions of the world have also 
shown that considerable overlap exists in  
thrombocytopenic values which occur in both uncompli-
cated and severe falciparum malarial infections.11-13 In 
non-endemic countries such as United Kingdom, France, 
Sweden, studies done showed a varying prevalence rate 
of thrombocytopenia in malaria to be between 64% - 
87.3%.14-17 In a study in Dakar, Senegal where malarial 
transmission is hypo-endemic, that is, low and season l, 
a prevalence of 56.2% was seen.18 In holoendemic ma-
laria countries like Pakistan, India, Kenya, Cameroon, 
and Nigeria, varying prevalence rates have been docu-
mented to be as low as 13% and as high as 90%.19-21 The 
prevalence of thrombocytopenia with falciparum parasi-
taemia has been mostly documented in adult populations 
of semi-immune and non-immune individuals, but there 
have been few documentation for children in the tropical 
region of Africa, more so in Nigeria, where malaria is 
endemic. This study was therefore designed to establish 
the prevalence of thrombocytopenia (platelet count <100 
x 109/L)7-9,19 in children aged six months to fifteen years 
with falciparum malaria infection as seen in a locality in 
Nigeria. The practice of paediatrics in the tropics does 
not always permit a detailed diagnostic work-up for
every child with haematological manifestations therefo e 
research on the prevalence and aetiologic patterns is 
important. It will serve as a guide to improve clinical 




Subjects and Methods 
 
The study was carried out in the Children Out-patient 
(CHOP) clinic, Children Emergency Unit (CHEU) and 
the Paediatric ward of the University of Uyo Teaching 
Hospital (UUTH), Uyo in Akwa-Ibom State. The Teach-
ing Hospital is the only tertiary health institution in the 
state, and is located on the outskirts of Uyo, six kilome-
tres from the centre of the city. Uyo, the capital city of 
Akwa-Ibom State is located in the South-south region of 
Nigeria. It lies between latitudes 4’33 and 5’33 North, 
longitudes 7’35 and 8’35 east, and falls within theropi-
cal zone where the anopheline mosquito habitat exiss.  
 
Approval for the study was obtained from the hospital’s 
Ethics committee before commencement. A written and 
verbal informed consent was obtained from each child if 
up to twelve years old and above or from the parents/
guardian(s) for younger children. 
 
Children aged six months to fifteen years of age with 
fever or a history of fever of not longer than seven days 
duration before presentation in hospital with parasi-
tologic evidence of malaria were included. Also in-
cluded were children with fever and at least one or m e 
features of severe malaria, as well as those who had not 
received any anti-malarial drug in the preceding two 
weeks of presentation to hospital. Any child who had 
received any cytotoxic drug and other drugs that inter-
fere with platelet counts e.g non-steroidal anti-
inflammatory drugs (NSAIDS) such as aspirin, Ibupro-
fen etc, within ten days of presentation, as well as those 
who had received any anti-malarial treatment within wo 
weeks of presentation were excluded. Children with 
systemic diseases e.g leukaemia and other malignancies 
that involve the bone-marrow and those with an obvius 
focus of infection, with a positive blood culture exami-
nation were all excluded. Controls were afebrile appar-
ently healthy children, matched for age and gender who
showed no signs of any systemic disease and had no 
parasitologic evidence of malaria. They were selectd 
from children attending child welfare clinic for growth 
monitoring and those presenting for immunization. Also 
children who presented to the out-patient clinic for
school entry medical examination were recruited. 
 
A clinical history was obtained from the care-giver and/
or the patient and included the onset and duration of 
fever (temperature ≥ 37.50Celsius) and associated symp-
toms. Uncomplicated malaria was established by micro-
scopically confirmed malaria parasitaemia with no 
symptoms of severity. Children with repeated convul-
sions, hyperpyrexia (axillary temperature ≥39.5ocelsius), 
respiratory distress, oliguria (urinary output < 1ml/kg/
hr), cardiovascular shock, jaundice, severe prostration, 
haemoglobinuria, severe anaemia (Haemoglobin<5g/dl), 
hyperparasitaemia (involving > 5% of erythrocytes), 
hypoglycaemia (serum glucose < 2.2mmol/l), acidosis 
(bicarbonate < 15mmol/l) were classified as having se-
vere malaria.3,4 Children presenting with an episode or 
repeated episodes of convulsions had a lumbar puncture 
done for cerebro-spinal fluid analysis to exclude bacte-
rial meningitis. A complete physical examination was 
done. Level of consciousness was assessed using the 
Blantyre’s score for children younger than two years nd 
Glasgow score for older children. 
 
Thick and thin blood films for malaria parasite were 
prepared directly from capillary blood and the slides 
stained on the same day with the Giemsa stain. Each 
blood film was examined microscopically using the 
100X objectives and the 7X eyepieces as these give a 
brighter and clearer image. The parasite density was
determined using the method by Greenwood and Arm-
strong22 who found this method to be more accurate and 
quicker than counting the parasites against white cells. 
The platelet count were determined using the fully auto-
mated blood cell analyser (Sysmex KX-21N). For any 
samples which contained a significant proportion of 
giant platelets, small platelets or did not show any plate-
let count, indicated by a flag signal from the machine, 
the manual counting method was performed for confir-
mation. 
 
Thrombocytopenia was defined in this study as a platelet 
count < 100,000 x 109/L.23-25 Severe thrombocytopenia 
was defined as a platelet count < 50,000 x 109/L.2 Aero-
bic and anaerobic blood cultures were done on each 
child. Random blood sugar was also done using a One-
Touch Ultra-2 glucometer (Life scan model Inc. 
Milpitas, CA.USA 95035) on every child presenting 
with clinical features of severe malaria. Values less than 
2.2mmol/l were considered as hypoglycaemia. 
29 
Statistical analysis  
 
Statistical analysis was performed using the SPSS 
(Statistical Analysis for Social Sciences) 17.0 software. 
Qualitative variables were expressed as number and 
percentage while quantitative variables were expressed 
as mean (X) and standard deviation (S).The arithmetic 
mean as a measure of central tendency, and the standard 
deviation (S) as a measure of dispersion where applied. 
The student t-test was used to compare the mean values 
of the quantitative variables between the subjects and
the controls. For non-normally distributed quantitative 
variables, the Wilcoxon rank sum test was employed. 
The Chi-square test was used in finding a difference i  
the qualitative variables. A p-value of less than 0.05 (p < 






A total of one hundred and eighty (180) subjects, and
one hundred and eighty (180) controls were studied. The 
group of children aged one to five years were the most, 
constituting 73.3% of subjects. The mean age of the 
subjects, 3.75 ± 4.20 years and that of control group 
3.78 ± 4.26 were comparable (p=0.96). The gender dis-
tribution and weight of subjects and controls were also 
comparable (p = 0.89). The mean temperature of sub-
jects at presentation was 37.8 ± 0.84 and their mean  
duration of fever was 3.27 ± 1.58 days. No child in the 
control group had fever. 
 
The mean malaria parasite count in subjects was 
25,650.28 ± 88,312.04, with a range of 500 to 725,500 
parasites/µl. P. falciparum was the only specie found in 
all the subjects. The control children had no parasitae-
mia. Platelet count was higher in the control group. This 
was statistically significant [(p = 0.0008) Fig I]. The 
platelet count range in subjects with uncomplicated ma-
laria was 70 - 596 x 109/L significantly greater than the 
range, 44 – 565 x 109/L in subjects with severe malaria 
(Table 1). 
 
Table 1: Platelet counts in subjects with uncomplicated versus 
severe malaria  
Clinical Malaria       Platelet ( x 109/L) P- value 
Range Mean ± SD 
Uncomplicated 70 – 596 313.95 ± 117.98   
























Box and Whisker Plot showing the distribution of platelet count in Subjects and Controls
Overall, nine (5.0%) of the 180 subjects in this study 
had thrombocytopenia, defined as platelet count < 100 x 
109/L. There was no individual with thrombocytopenia 
among the controls. Of the 156 subjects presenting with 
uncomplicated malaria, three (1.9%) had thrombocyto-
penia, while six (25.0%) of the 24 subjects with sever  
malaria had thrombocytopenia. Of these, one subject 
(0.6%) had severe thrombocytopenia (defined by a 
platelet count < 50 x 109/L). This difference was statisti-
cally significant [(p < 0.001) Table 2a]. Comparatively, 
using a reference thrombocytopenic cut-off value of 150 
x 109/L in this study, twenty-three (12.8%) of the 180 
subjects would be seen to have thrombocytopenia. Of 
these, thirteen (54.2%) presented with severe malaria 
and ten (6.4%) with uncomplicated malaria. This was 
also statistically significant [(p < 0.001) Table 2b]. 
 
Table 2a: Prevalence of thrombocytopenia (<100,000) in  
clinical malaria 
 




       
Discussion 
   
The low prevalence of 5.0% of thrombocytopenia in 
falciparum malaria found in this study is comparable to 
the 13.75% found by Jeremiah and Uko in Port-
Harcourt.19 This finding may be as a result of the throm-
bocytopenic cut-off range of 100 x 109/L used in both 
studies.  Besides this, the children in that community 
study done in Port-harcourt were asymptomatic for ma-
laria, which may otherwise, have had more profound 
effect on their platelet counts. Both studies were carried 
out in the south-south region of Nigeria, with similar 
levels of malaria transmission. The low prevalence rat s 
obtained in both studies, may be due to the early acqui-
sition of malarial immunity by many children in these 
holo-endemic study settings which confers a protectiv  
effect against severe manifestations including thromb -
cytopenia.17 This immunity seems to vary in children 
from region to region3 and may be a possible factor re-
sponsible for the low prevalence observed in both  
studies. 
 
The higher prevalence of 23% to 59.7% documented in 
other studies carried out in the south-western part of 




Subjects Total P-value 
Uncompli-
cated N % 
Severe 
N % 
> 100,000 153 (98%)  18 (75%) 171 (95%)   




Subjects Total P-value 
Uncompli-
cated  N% 
Severe 
N % 
> 150,000 146(93.6%) 11(45.8%) 157(87.2%)   
<150,000 10 (6.4%) 13(54.2%)  23(12.8%) 0.001 
30 
study. These differences in prevalence may be partly 
explained by the different age distributions of thechil-
dren studied, the clinical severity of malaria in the 
groups studied, and the platelet cut-off reference ranges 
used by the different authors. These studies were hospi-
tal-based, had more children with severe malaria in-
cluded and children with bacterial infections were not 
excluded. These may have contributed greatly to their 
higher prevalence rates of thrombocytopenia, consider-
ing the synergistic effect of these factors on depression 
of platelet count values. These authors23,24 also both in-
explicably used a thrombocytopenic cut-off range of 150 
x 109/L in defining thrombocytopenia, rather than the 
accepted normal range of 100 x 109/L used in present 
study, being the standard reference range for the African 
population.9,19  
 
Outside Nigeria, higher prevalence rates of 49% and
58% were also documented among children in Kenya25 
and Gabon26 respectively, who live in similar tropical 
settings with stable malaria and perennial transmision. 
A higher cut-off of platelet reference value of 150 x 109/
L was also used in these studies. This seems to have
contributed significantly to the higher prevalence docu-
mented. As compared to this study, a higher prevalence 
was also obtained from children in Dakar18 (56.2%) and 
France16 (45.6%), being areas of hypo-endemic and non-
endemic transmission of malaria respectively. This may 
be because children in these hypo and non-endemic ar-
eas of transmission are mostly non-immune to ma-
laria.2,16,18 They are therefore at a higher risk of severe 
clinical manifestations of malaria, with its attenda t 
lowering effects on platelet count values. Besides, the 
prospective study in Dakar was done over a prolonged 
period of seventeen months, and children with severe 
malaria comprised a greater percentage (74.7%) of the 
study population. This probably explains the low plate et 
count values. This re-inforces the importance of a close 
monitoring of the platelet counts in children visiting 
from non-endemic settings, since they are at greater risk 
of thrombocytopenia. 
The significantly lower platelet count in the children 
with malaria parasitaemia than those in the control 
group is an observation similar to that made by Aking-
bola et al23 and Iwalokun et al24 in Lagos, Nigeria. Like-
wise, the normal platelet count values seen in the control 
children in this study as also observed by Akingbola et 
al23 all serve to affirm the adverse effect of malaria para-
sitaemia on platelet count values. The reduced platelet 
lifespan and platelet destruction in acute malaria, which 
partly results from the binding of malaria antigen u to 
platelets is perhaps responsible for the above findings. 
This observation was found to be irrespective of the
malaria transmission level or specie in the areas  
studied.21  
 
Children with severe manifestations of malaria had sig-
nificantly lower platelet counts than those with uncom-
plicated malaria in this study similar to previous reports 
in other Nigerian children.23,24 Reduction in platelet 
count values, which is a more frequent finding in severe 
forms of malaria, would have been responsible for the 






In conclusion, although the overall prevalence of throm-
bocytopenia in children with falciparum malaria in our 
locality is low, it is significantly higher in children with 
severe manifestations of malaria than in the uncompli-
cated type. It is recommended where possible, to evalu-
ate and monitor the platelet counts in children presenting 
with clinical features of severe malaria. It would also be 
beneficial to use standardized normal reference values 
representing children living in similar geographical set-
tings. 
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